-

CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cardiovascular Systems, Inc. (“CSI”) (NasdaqGS: CSII) to Abbott Laboratories (NYSE: ABT). Under the terms of the proposed transaction, shareholders of CSI will receive $20.00 in cash for each share of CSI that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-csii/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com..

Contacts

Kahn Swick & Foti, LLC
Lewis S. Kahn, 855-768-1857
KSF Managing Partner
lewis.kahn@ksfcounsel.com

Industry:

Kahn Swick & Foti, LLC

NASDAQ:CSII
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis S. Kahn, 855-768-1857
KSF Managing Partner
lewis.kahn@ksfcounsel.com

More News From Kahn Swick & Foti, LLC

THE BANCORP SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Bancorp, Inc. - TBBK

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 19, 2025 to file lead plaintiff applications in a securities class action lawsuit against The Bancorp, Inc. (“Bancorp” or the “Company”) (NasdaqGS: TBBK), if they purchased the Company’s securities between January 25, 2024 and March 4, 2025, inclusive (the “Class Period”). This action is pending in the...

SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Sage Therapeutics, Inc. (“Sage” or “the Company”) (NasdaqGM: SAGE). Sage is a biopharmaceutical company that develops and commercializes brain health medicines. On April 17, 2024, the Company disclosed that a Phase 2 study of its SAGE-718 product “did not meet its primary...

CHIPOTLE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Chipotle Mexican Grill, Inc. - CMG

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Chipotle Mexican Grill, Inc. (“the Company”) (NYSE: CMG). Beginning in the spring of 2024, news reports highlighted grievances lodged by Chipotle customers regarding the Company’s inconsistent or inadequate portion size. In response, the Company announced efforts to incre...
Back to Newsroom